Publicaciones en las que colabora con J. A. Vázquez de Prada (16)

2022

  1. Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 129-140

2021

  1. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926

2015

  1. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  2. Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42

2014

  1. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

    International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23

2013

  1. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation

    Clinical Transplantation, Vol. 27, Núm. 6

2012

  1. Comments on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 874-878

  2. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 31, Núm. 3, pp. 288-295

2011

  1. Risk factors associated with cytomegalovirus infection in heart transplant patients: A prospective, epidemiological study

    Transplant Infectious Disease, Vol. 13, Núm. 2, pp. 136-144

2010

  1. Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 4

  2. Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 5, pp. 194-200

  3. Temporal trends in the use of proliferation signal inhibitors in maintenance heart transplantation: A Spanish multicenter study

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2997-3000

2009

  1. Steroid Use in Heart Transplant Patients in Spain in the Current Era: A Multicenter Survey

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2244-2246

2008

  1. Malignancy after heart transplantation: Incidence, prognosis and risk factors

    American Journal of Transplantation, Vol. 8, Núm. 5, pp. 1031-1039

2007

  1. Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry

    Journal of Heart and Lung Transplantation, Vol. 26, Núm. 11, pp. 1105-1109